Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ABT

This Top-Rated Healthcare Stock Is Trading at a 25% Discount

Medical device company Abbott Laboratories (ABT) reported impressive first-quarter results and affirmed its strong performance guidance for fiscal 2022. Furthermore, the company is well-positioned to benefit from its diversified business. However, amid the heightened market volatility, the stock is trading 25.5% below its 52-week high. So, the current dip in…

StockNews.com

FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens

Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at Abbott's Sturgis facility.

Benzinga

5 Dividend Aristocrats To Buy Now

Last week, the Fed raised its benchmark interest rates three-quarters of a percentage point, marking the most aggressive hike since 1994. And with analysts predicting the economy to slip into a recession, we think dividend aristocrats Abbott (ABT), AbbVie (ABBV), Genuine Parts (GPC), Johnson & Johnson (JNJ), and Sysco (SYY)…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

DTM Imola: Rookie Feller snares maiden pole in Abt Audi

Ricardo Feller took his first DTM pole position in a frenetic qualifying session at Imola on Sunday as the Abt Audi driver pipped Felipe Fraga's Red Bull Ferrari by 0.152s.

Autosport

Imola DTM: Audi's Rast claims first pole since return

Rene Rast became the fifth different polesitter from as many DTM races in 2022 as he snatched top spot with a late effort for the championship's first race at Imola.

Motorsport

DTM Imola: Rast takes first pole of his comeback over Muller

Rene Rast became the fifth different polesitter from as many DTM races in 2022 as he snatched top spot with a late effort for the championship's first race at Imola.

Autosport

More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant

Just a few weeks after reopening its baby formula Sturgis, Michigan plant, Abbott Laboratories (NYSE:ABT) said it paused EleCare specialty baby formula production after recent thunderstorms flooded part of the facility. The company has informed the FDA and will conduct comprehensive testing with an independent third party to ensure the plant is safe to…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Kelvin van der Linde confident Lausitzring DTM struggles are resolved

DTM race-winner Kelvin van der Linde says he understands the problems that blighted his Lausitzring weekend and believes his Nurburgring 24 Hours victory was 'perfect to get my confidence back'.

Autosport

Van der Linde confident Lausitz DTM struggles are resolved

DTM race-winner Kelvin van der Linde says he understands the problems that blighted his Lausitzring weekend and believes his Nurburgring 24 Hours victory was 'perfect to get my confidence back'.

Motorsport

5 Hard-Hit Large-Cap Stocks Ready to Rebound

The market turmoil this year, due to the sky-high inflation and the Fed’s hawkish tilt, has led several fundamentally solid large-cap stocks to trade below their intrinsic values. However, we believe quality large-cap stocks Broadcom (AVGO), Abbott (ABT), IQVIA (IQV), Agilent (A), and QUALCOMM (QCOM), which have declined significantly in…

StockNews.com

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.54% on an annualized basis producing an average annual return of 14.5%. Currently, Abbott Laboratories has a market capitalization of $201.08 billion.

Benzinga

Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?

The growing prevalence of chronic diseases, an increasing elderly population, and rapid adoption of advanced medical technologies are driving the growth of the medical device industry. The industry is expected to witness solid growth over the long term, to the benefit of the stocks of medical device companies Abbott (ABT)…

StockNews.com

Mahindra confirms talks with Abt for Formula E powertrain supply

Mahindra Racing is holding talks with several Formula E teams including Abt Sportsline to supply customer powertrains for the start of the Gen3 era in 2023.

Motorsport

Abbott vs. Stryker: Which Medical Devices Stock is a Better Investment?

Given the increasing investments in R&D and technological integrations, and the rebounding demand for critical surgical procedures, the medical devices industry is well-positioned to grow. This should benefit Abbott (ABT) and Stryker (SYK). But which of these stocks is a better buy now?.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.65% on an annualized basis producing an average annual return of 14.68%. Currently, Abbott Laboratories has a market capitalization of $203.74 billion.

Benzinga

Lawmakers Seek Answers From FDA, Abbott On Nationwide Baby Formula Shortage

FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE: ABT) recalled some baby formula products and closed its manufacturing plant in Sturgis, Michigan.

Benzinga

FDA Allows Import Of 2M Baby Formula Cans Amid Supply Shortage: Reuters

The FDA is easing regulations to allow infant formula imports from Britain, bringing around 2 million cans onto empty shelves by June to ease a nationwide shortage, Reuters reported. The FDA said it was "exercising enforcement discretion" to allow Britain-based Kendal Nutricare to import certain infant formula products under the Kendamil…

Motorsport

Rast explains “upside-down” set-up change behind DTM podium return

Three-time DTM champion Rene Rast said a set-up rethink gave him a “different car” for the second Lausitzring race and helped him to score the first podium of his comeback.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Abbott's Troubled Baby Formula Michigan Plant To Reopen In 1-2 Weeks: Reuters

Abbott Laboratories (NYSE:ABT) and the FDA are reportedly on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said. Abbott, the biggest U.S. supplier of powder infant formula, including Similac, agreed with the FDA on the steps needed to resume production at…

Benzinga

US Lawmakers Reveal FDA Emergency Funds Bill To Tackle Baby Formula Shortage: Reuters

U.S. House Democrats unveiled a bill to provide $28 million in emergency funds to the FDA to help it respond to a shortage of infant formula and strengthen supervision. A House Appropriations Committee said that the funds would provide the FDA with the resources to prevent fraudulent products from being placed on…

Autosport

Why Audi’s newest GT ace will be a Feller to watch in DTM

Winning the ADAC GT Masters title capped a breakout 2021 for Ricardo Feller, who joined Audi’s factory stable as a result. The new face in Abt’s all-star DTM line-up, his promising start in Portugal suggests the Swiss driver won’t be a junior partner to his storied team-mates

Benzinga

US Baby Formula Crisis Could See Some Relief As FDA, Abbott Agree On Deal

The baby formula shortage that has morphed into a crisis in the U.S. could soon see some relief following an agreement between market leader Abbott Laboratories (NYSE: ABT) and the Food and Drug Administration.

Motorsport

McLaren entry a "huge rebound" for Formula E - Agag

McLaren's entry into Formula E is a 'huge rebound' for the championship after losing a number of manufacturer teams last season, according to chairman and founder Alejandro Agag.

Autosport

McLaren Formula E entry a "huge rebound" for championship - Agag

McLaren's entry into Formula E is a 'huge rebound' for the championship after losing a number of manufacturer teams last season, according to chairman and founder Alejandro Agag.

Motor1

ABT Audi RS6 Avant Tries To Beat Huracan STO In Close Drag Races

The wagon makes 790 horsepower to the Lamborghini’s 640.

1 … 8 9 10 11

People

Joe Biden

64,713 stories

Mangeet Kaur BounsMangeet

Sheldon van der Linde

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.